TO# 2018-02; NExT Z-Endoxifen CT025-402-448-004 - API Batch analysis Milestone 4, Analysis of Anti-Cancer Chemical & Pharmaceutical Formulations, HHSN261201700011I, DTP-18-022, 5/15 - 8/15/18,
$7,307N02FY2018CANIH
Midwest Research Institute, Kansas City MO
Investigators
Abstract
The analysis of bulk drug lots to be used in clinical trial, according to FDA regulations.
View original record on NIH RePORTER →